The only safe assumption to make about today’s current gold standard imaging modality used to identify and evaluate atheromatous plaque in the peripheral arteries is that there is not one gold standard. To locate and evaluate these plaques that cause peripheral vascular disease (PVD), physicians have multiple tried-and-true imaging tests at their disposal.
July 10, 2008 - Datascope Corp. said today it exercised its option to acquire the Peripheral Vascular Stent business of ...
Safe delivery of the balloon or stent through fragile vasculature during percutaneous transluminal coronary angioplasty (PTCA) procedures is an important criterion for successful patient outcomes.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
July 10, 2008 - A novel blood pool magnetic resonance angiography (MRA) agent, Vasovist (gadofosveset trisodium), has ...
Cardiology fellows are expanding their knowledge in cardiovascular imaging. Not only do virtually all cardiology fellows get Level 2 training in echocardiography and many in nuclear cardiology but now, an increasing number of fellows are training in cardiac MR and cardiac CT.
What makes cardiologists more capable of reading cardiac imaging exams than other physicians such as radiologists, who ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
July 10, 2008 - The Senate overcame partisan gridlock on July 9, 2008, and passed the Medicare Improvements for Patients ...
(Editor's note: this article was updated in March 2017 with links at the bottom to more current stent technology ...
Physicians recognize the importance of ventricular assist devices (VADs) every time a congestive heart failure (CHF) ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
InTouch Technologies Inc. offers StrokeRESPOND to extend the functionality of its telemedicine, Remote Presence robotic ...
Thoratec Corp. received FDA approval of its PMA (premarket approval) application, allowing the use of its HeartMate II LVAS (left ventricular assist system) as a bridge-to-transplantation (BTT) in patients suffering from advanced-stage heart failure.
Northeast Monitoring’s DR200/HE is a combination 14-day Holter plus 30-day Event recorder integrated into a single unit ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
July 10, 2008 - The XIV Congress of the Latin American Society of Interventional Cardiology (SOLACI) and the annual ...
The FDA cleared GE Healthcare’s new LightSpeed CT750 HD, said to be the world’s first high-definition CT scanner that ...
Vascular Insights received 510(k) clearance from the FDA to market its ClariVein infusion catheter for infusion of physician-specified agents in the peripheral vasculature. ClariVein is a percutaneous, 2 2/3 Fr (0.035-inch) catheter, containing a rotating wire driven by a motor, that enhances fluid dispersion in the treatment area.
July 09, 2008
